GeorgeJabbourMDFACC FSCAI
Cardiology • Altoona, PAAdult Congenital Heart Disease, Echocardiography, Interventional Cardiology, Nuclear Cardiology
Chair, Clinical Department of Cardiology, Medical Director, Cardiac Cath Lab, UPMC Altoona
Dr. Jabbour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1414 9th Ave
# Station
Altoona, PA 16602Phone+1 814-946-1655Fax+1 814-949-7616
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Interventional Cardiology, 2008 - 2009- SUNY Downstate Health Sciences UniversityFellowship, Cardiovascular Disease, 2005 - 2008
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2003 - 2004
Lebanese University School of MedicineClass of 1998
Certifications & Licensure
PA State Medical License 2009 - 2024
TX State Medical License 2009 - 2011
CT State Medical License 2008 - 2009
NY State Medical License 2006 - 2009- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- AHA Hall of Fame American Heart Association, 2015
- FSCAI SCIA, 2014
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 126 citationsPredictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionTrevor Simard, Richard G. Jung, Kyle Lehenbauer, Kerstin Piayda, Radosław Pracoń
Journal of the American College of Cardiology. 2021-07-27 - 4 citationsPersistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.Jules Mesnier, Trevor Simard, Richard G Jung, Kyle R Lehenbauer, Kerstin Piayda
JACC. Cardiovascular Interventions. 2023-11-27 - 22 citationsChronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.Chukwuka C Okafor, Cynthia Perreault-Micale, Roger J. Hajjar, Djamel Lebeche, Klara Skiroman
BMC Physiology. 2003-07-21
Press Mentions
- UPMC Altoona’s Heart-Saving Cath Lab Is a Team EffortOctober 30th, 2020
An Alternative to Blood Thinners: Learn About the WATCHMAN™December 13th, 2019
Tim’s Story: One Man’s Recovery from ‘Broken Heart Syndrome’July 6th, 2018
Professional Memberships
- Member
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
